Drug Shortage Report for NABUMETONE

Last updated on 2018-08-22 History
Report ID 25296
Drug Identification Number 02238639
Brand name APO-NABUMETONE
Common or Proper name NABUMETONE
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) NABUMETONE
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code M01AX
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-09
Estimated end date 2018-08-15
Actual end date 2018-08-21
Shortage status Resolved
Updated date 2018-08-22
Company comments
Health Canada comments
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-10-11 English Compare
v2 2017-10-11 French Compare
v3 2017-11-07 English Compare
v4 2017-11-07 French Compare
v5 2017-12-01 English Compare
v6 2017-12-01 French Compare
v7 2018-04-11 English Compare
v8 2018-04-11 French Compare
v9 2018-06-25 English Compare
v10 2018-06-25 French Compare
v11 2018-08-21 English Compare
v12 2018-08-21 French Compare
v13 2018-08-22 English Compare